Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V; TESTING Study Group. Lv J, et al. Among authors: feehally j. JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362. JAMA. 2017. PMID: 28763548 Free PMC article. Clinical Trial.
IgA nephropathy: recent developments.
Floege J, Feehally J. Floege J, et al. Among authors: feehally j. J Am Soc Nephrol. 2000 Dec;11(12):2395-2403. doi: 10.1681/ASN.V11122395. J Am Soc Nephrol. 2000. PMID: 11095664 Review. No abstract available.
Corticosteroid therapy in IgA nephropathy.
Lv J, Xu D, Perkovic V, Ma X, Johnson DW, Woodward M, Levin A, Zhang H, Wang H; TESTING Study Group. Lv J, et al. J Am Soc Nephrol. 2012 Jun;23(6):1108-16. doi: 10.1681/ASN.2011111112. Epub 2012 Apr 26. J Am Soc Nephrol. 2012. PMID: 22539830 Free PMC article. Review.
The mucosa-kidney axis in IgA nephropathy.
Floege J, Feehally J. Floege J, et al. Among authors: feehally j. Nat Rev Nephrol. 2016 Mar;12(3):147-56. doi: 10.1038/nrneph.2015.208. Epub 2015 Dec 30. Nat Rev Nephrol. 2016. PMID: 26714580 Review.
An update on the treatment of IgA nephropathy.
Barbour S, Feehally J. Barbour S, et al. Among authors: feehally j. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):319-326. doi: 10.1097/MNH.0000000000000336. Curr Opin Nephrol Hypertens. 2017. PMID: 28399021 Review.
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC; International IgA Nephropathy Network. Barbour SJ, et al. Among authors: feehally j. JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600. JAMA Intern Med. 2019. PMID: 30980653 Free PMC article.
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
Wong MG, Lv J, Hladunewich MA, Jha V, Hooi LS, Monaghan H, Zhao M, Barbour S, Reich HN, Cattran D, Glassock R, Levin A, Jardine MJ, Wheeler DC, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Zhang H, Perkovic V; TESTING Study Group. Wong MG, et al. Among authors: feehally j. Am J Nephrol. 2021;52(10-11):827-836. doi: 10.1159/000519812. Epub 2021 Nov 3. Am J Nephrol. 2021. PMID: 34731857 Free PMC article.
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, Zhao M, Barbour S, Jardine MJ, Reich HN, Cattran D, Glassock R, Levin A, Wheeler DC, Woodward M, Billot L, Stepien S, Rogers K, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Zhang H, Perkovic V; TESTING Study Group. Lv J, et al. Among authors: feehally j. JAMA. 2022 May 17;327(19):1888-1898. doi: 10.1001/jama.2022.5368. JAMA. 2022. PMID: 35579642 Free PMC article. Clinical Trial.
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al. Among authors: feehally j. Kidney Int. 2009 Sep;76(5):534-45. doi: 10.1038/ki.2009.243. Epub 2009 Jul 1. Kidney Int. 2009. PMID: 19571791 Free article.
IgA nephropathy at two score and one.
Coppo R, Feehally J, Glassock RJ. Coppo R, et al. Among authors: feehally j. Kidney Int. 2010 Feb;77(3):181-6. doi: 10.1038/ki.2009.427. Epub 2009 Nov 18. Kidney Int. 2010. PMID: 19924103 Free article.
340 results